Menopause & HormonesEvidence check
Venlafaxine or Estradiol for Hot Flashes: Four Checks
Both reduced symptoms beyond placebo; the comparison does not prove equivalence.
Free shipping
ArticlesTopic 09
Hot flashes, night sweats and the body that suddenly changed the rules.
Menopause & HormonesEvidence check
Both reduced symptoms beyond placebo; the comparison does not prove equivalence.
Menopause & HormonesEvidence check
The eight-week study measured counts and weighted severity separately.
Menopause & HormonesExplainer
Earlier hormone-responsive depression deserves a place in the discussion before changing treatment.
Menopause & HormonesComparison
VEMORA adds symptom evidence for breast-cancer survivors. Recurrence risk remains a separate treatment question.
Menopause & HormonesEvidence check
OASIS-4 found fewer hot flashes during endocrine therapy. Its selected population, 12-week placebo comparison and reported adverse events define what that result can support.
Menopause & HormonesEvidence check
An eight-week trial found fewer diary-recorded flashes. Smaller recorder studies and current prescribing warnings add context.
Menopause & HormonesEvidence check
The EU indication, weekly hot-flash results, dose terminology and uterine-lining precautions.
Menopause & HormonesEvidence check
What changed in short crossover studies, who was excluded and why prescribing needs a separate assessment.
Menopause & HormonesEvidence check
What the six-week trial measured, how side effects varied and why the US menopause society advises against this use.
Menopause & HormonesEvidence check
The early response rate, a small breast-cancer trial and a 2026 combination study answer different questions.
Menopause & HormonesEvidence check
The seed-oil trial's twelve-week result differed from its later visit. A second study measured broader menopause symptoms.
Menopause & HormonesEvidence check
The research concerns a specified root extract. Its short placebo trials, later follow-up reports and cancer study answer different questions.